Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M305410200 on June 24, 2003

J. Biol. Chem., Vol. 278, Issue 36, 34451-34457, September 5, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/36/34451    most recent
M305410200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sharpe, I. A.
Right arrow Articles by Lewis, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sharpe, I. A.
Right arrow Articles by Lewis, R. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Allosteric {alpha}1-Adrenoreceptor Antagonism by the Conopeptide {rho}-TIA*

Iain A. Sharpe {ddagger} §, Linda Thomas {ddagger}, Marion Loughnan {ddagger}, Leonid Motin §, Elka Palant ¶, Daniel E. Croker ¶, Dianne Alewood ¶, Songhai Chen ||, Robert M. Graham ||, Paul F. Alewood {ddagger}, David J. Adams § and Richard J. Lewis {ddagger} § **

From the {ddagger}Institute for Molecular Bioscience and the §School of Biomedical Sciences, The University of Queensland, St. Lucia 4072, Queensland, Australia, Xenome Ltd., 50 Meiers Road, Indooroopilly 4068, Queensland, Australia, and the ||Molecular Cardiology Unit, Victor Chang Cardiac Research Institute, Darlinghurst 2010, New South Wales, Australia

A peptide contained in the venom of the predatory marine snail Conus tulipa, {rho}-TIA, has previously been shown to possess {alpha}1-adrenoreceptor antagonist activity. Here, we further characterize its pharmacological activity as well as its structure-activity relationships. In the isolated rat vas deferens, {rho}-TIA inhibited {alpha}1-adrenoreceptor-mediated increases in cytosolic Ca2+ concentration that were triggered by norepinephrine, but did not affect presynaptic {alpha}2-adrenoreceptor-mediated responses. In radioligand binding assays using [125I]HEAT, {rho}-TIA displayed slightly greater potency at the {alpha}1B than at the {alpha}1A or {alpha}1D subtypes. Moreover, although it did not affect the rate of association for [3H]prazosin binding to the {alpha}1B-adrenoreceptor, the dissociation rate was increased, indicating non-competitive antagonism by {rho}-TIA. N-terminally truncated analogs of {rho}-TIA were less active than the full-length peptide, with a large decline in activity observed upon removal of the fourth residue of {rho}-TIA (Arg4). An alanine walk of {rho}-TIA confirmed the importance of Arg4 for activity and revealed a number of other residues clustered around Arg4 that contribute to the potency of {rho}-TIA. The unique allosteric antagonism of {rho}-TIA resulting from its interaction with receptor residues that constitute a binding site that is distinct from that of the classical competitive {alpha}1-adrenoreceptor antagonists may allow the development of inhibitors that are highly subtype selective.


Received for publication, May 23, 2003

The atomic coordinates and structure factors (code 1IEN) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).

* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

** To whom correspondence should be addressed: Institute for Molecular Bioscience, The University of Queensland, St. Lucia 4072, QLD, Australia. Tel.: 61-7-3346-2984; Fax: 61-7-3346-2101; E-mail: r.lewis{at}imb.uq.edu.au.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Neurosci.Home page
B. Callaghan, A. Haythornthwaite, G. Berecki, R. J. Clark, D. J. Craik, and D. J. Adams
Analgesic {alpha}-Conotoxins Vc1.1 and Rg1A Inhibit N-Type Calcium Channels in Rat Sensory Neurons via GABAB Receptor Activation
J. Neurosci., October 22, 2008; 28(43): 10943 - 10951.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
K. A. Beaumont, S. L. Shekar, R. A. Newton, M. R. James, J. L. Stow, D. L. Duffy, and R. A. Sturm
Receptor function, dominant negative activity and phenotype correlations for MC1R variant alleles
Hum. Mol. Genet., September 15, 2007; 16(18): 2249 - 2260.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. M. Finch and R. M. Graham
The {alpha}1D-Adrenergic Receptor: Cinderella or Ugly Stepsister
Mol. Pharmacol., January 1, 2006; 69(1): 1 - 4.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Chen, G. Rogge, C. Hague, D. Alewood, B. Colless, R. J. Lewis, and K. P. Minneman
Subtype-selective Noncompetitive or Competitive Inhibition of Human {alpha}1-Adrenergic Receptors by {rho}-TIA
J. Biol. Chem., August 20, 2004; 279(34): 35326 - 35333.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement